Fracture risks of antidepressants

Expert Review of Neurotherapeutics

Volumn 9, Issue 1, 2009, Pages 137-141

  Vestergaard, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antidepressant; Fracture; Selective serotonin reuptake inhibitor; Tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; IMIPRAMINE; ISOCARBOXAZID; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE B INHIBITOR; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; REBOXETINE; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BONE DENSITY; DEPRESSION; FALLING; FRACTURE; HEART RATE; HIP FRACTURE; HUMAN; OSTEOBLAST; OSTEOCLAST; REVIEW; SIDE EFFECT; SPINE FRACTURE; SYSTOLIC BLOOD PRESSURE; VERTEBRA FRACTURE;

ACCIDENTAL FALLS; ANTIDEPRESSIVE AGENTS; BONE DENSITY; FRACTURES, BONE; HUMANS; RISK FACTORS;

EID: 58149235165     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.9.1.137     Document Type: Review

References (27)

1. Videbech P, Sparle Christensen K, Buchholtz Hansen PE. Antidepressiva. In: Medicin.dk 2007. Pedersen C, Bjerrum L, Dalhoff KP, Damkier P, Friis H, Hendel J (Eds). Infomatum A/S, Copenhagen, Denmark, 373-386 (2007).
2. Eskandari F, Martinez PE, Torvik S et al. Low bone mass in premenopausal women with depression. Arch. Intern. Med. 167, 2329-2336 (2007).
3. Robbins J, Hirsch C, Whitmer R, Cauley J, Harris T. The association of bone mineral density and depression in an older population. J. Am. Geriatr. Soc. 49, 732-736 (2001).
4. Michelson D, Stratakis C, Hill L et al. Bone mineral density in women with depression. N. Engl. J. Med. 335, 1176-1181 (1996).
5. Schweiger U, Weber B, Deuschle M, Heuser I. Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am. J. Psychiatry 157, 118-120 (2000).
6. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159, 484-490 (1999).
7. Reginster JY, Deroisy R, Paul I, Hansenne M, Ansseau M. Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas 33, 133-137 (1999).
8. Spangler L, Scholes D, Brunner RL et al. Depressive symptoms, bone loss, and fractures in postmenopausal women. J. Gen. Intern. Med. 23, 567-574 (2008).
9. Pollock BG. Adverse reactions of antidepressants in elderly patients. J. Clin. Psychiatry 60 (Suppl. 20), 4-8 (1999).
10. Christensen P, Thomsen HY, Pedersen OL, Gram LF, Kragh-Sorensen P. Orthostatic side effects of clomipramine and citalopram during treatment for depression. Psychopharmacology (Berl.) 86, 383-385 (1985).
11. Rodriguez dlT, Dreher J, Malevany I et al. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Ther. Drug Monit. 23, 435-440 (2001).
12. Bliziotes M, Gunness M, Eshleman A, Wiren K. The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice. J. Musculoskelet. Neuronal Interact. 2, 291-295 (2002).
13. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146, 685-693 (2005).
14. Haney EM, Chan BKS, Diem SJ et al; for the Osteoporotic Fractures in Men Study Group. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch. Int. Med. 167, 1246-1251 (2007). • Key study on bone mineral density and selective serotonin reuptake inhibitor and tricyclic antidepressant use.
15. Richards JB, Papaioannou A, Adachi JD et al.; for the Canadian Multicentre Osteoporosis Study (CaMos) research group. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch. Int. Med. 167, 188-194 (2007).
16. Diem SJ, Blackwell TL, Stone KL et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch. Int. Med. 167, 1240-1245 (2007).
17. Williams LJ, Henry MJ, Berk M, Dodd S, Jacka FN, Kotowicz MA. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int. Clin. Psychopharmacol. 23, 84-87 (2008).
18. Schneeweiss S, Wang PS. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims studies. J. Clin. Psychopharmacol. 24, 632-638 (2004).
19. Ensrud KE, Blackwell T, Mangione CM et al. Central nervous system active medications and risk for fractures in older women. Arch. Intern. Med. 163, 949-957 (2003).
20. Mussolino ME. Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep. 120, 71-75 (2005).
21. Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporosis Int. 17, 807-816 (2006).
22. Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am. J. Epidemiol. 158, 77-84 (2003).
23. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351, 1303-1307 (1998).
24. Vestergaard P, Rejnmark L, Mosekilde L. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif. Tissue Int. 82, 92-101 (2008). •• A detailed study on fracture risk in users of many subtypes of antidepressants.
25. Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J. Clin. Psychopharmacol. 28, 411-417 (2008).
26. Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD. Fracture risk from psychotropic medications: a population-based analysis. J. Clin. Psychopharmacol. 28, 384-394 (2008).
27. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312, 1254-1259 (1996).